Impact of hypertension on the outcomes in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention. | ||
| ALEXMED ePosters | ||
| Article 1, Volume 6, Issue 4, September 2024, Pages 50-51 | ||
| Document Type: Preliminary preprint short reports of original research | ||
| DOI: 10.21608/alexpo.2024.333117.1990 | ||
| Authors | ||
| Mohamed Ahmed Sadaka1; Gehan Magdy2; Ahmed Mahmoud El Amrawy3; Godfried G M Salanga* 4 | ||
| 1Departement of Cardiology and Angiology of Medecine,University of Alexandria. | ||
| 2Department of Cardiology, Faculty of Medicine, Alexandria University | ||
| 3Department of Cardiology and Angiology, Faculty of Medicine- Alexandria University | ||
| 4Department of Cardiology and Angiology, Faculty of Medicine, Alexandria University, Egypt | ||
| Abstract | ||
| Introduction: Cardiovascular disease (CVD) is a major global health issue affecting the heart and blood vessels, causing about one-third of global mortality. It has been a cause of death since ancient civilisations, with mummies showing signs of CVD in ancient Egyptian hieroglyphic papyri texts. In 2020, CVD caused 19.1 million deaths globally, with the burden estimated at 523 million cases and 18.6 million deaths. The most common cardiovascular diseases causing mortality and disability are ischemic heart disease and stroke. The United Nations set a goal to reduce CVD deaths by 30% by 2030, as if not addressed, mortality due to CVD is expected to increase to 23.6 million and the global economic burden to $1044 billion by 2030. CVD is also found in lower and middle-income countries, with Eastern Europe and Central Asia having the highest mortality rates. By 2030, CVD is expected to cause more than half of all deaths in Africa, making it a leading cause of morbidity and mortality. | ||
| Keywords | ||
| hypertension; primary PCI; outcomes | ||
|
Statistics Article View: 4 |
||
